CYP2D6 gene polymorphism in psychiatric patients resistant to standard pharmacotherapy

被引：0
|
作者：
Zabrocka, M
Woszczek, G
Kowalski, ML
Borowiec, M
Zaborowski, A
机构：
[1] MED UNIV LODZ,DEPT PSYCHIAT 1,LODZ,POLAND
[2] MED UNIV LODZ,DEPT CLIN IMMUNOL & ALLERGY,LODZ,POLAND
来源：
AMERICAN JOURNAL OF MEDICAL GENETICS | 1997年 / 74卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：634 / 634
页数：1
相关论文
共 50 条
  • [21] Significance of the genetic polymorphism of CYP2D6 in patients with bullous pemphigoid
    Rychlik-Sych, Mariola
    Baranska, Malgorzata
    Wojtczak, Anna
    Skretkowicz, Jadwiga
    Zebrowska, Agnieszka
    Waszczykowska, Elzbieta
    PHARMACOLOGICAL REPORTS, 2015, 67 : 37 - 38
  • [22] CYP2D6 genetic polymorphism and psychiatry patients' hospitalization period
    Penas-LLedo, Eva M.
    LLerena, Adrian
    BIOMARKERS IN MEDICINE, 2013, 7 (06) : 915 - 916
  • [23] Effects of CYP2D6 polymorphism on response to rosuvastatin in Chinese patients
    Tomlinson, B.
    Lui, S. S. H.
    Hu, T. M.
    Chu, T. T. W.
    Poon, E.
    Baum, L.
    Ko, G. T. C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 62 - 63
  • [24] Interethnic differences in the CYP2D6 polymorphism with emphasis on gene duplication/amplification
    Bertilsson, L
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R15 - R15
  • [25] CYP2D6 genotypes in a Japanese population:: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10
    Nishida, Y
    Fukuda, T
    Yamamoto, I
    Azuma, J
    PHARMACOGENETICS, 2000, 10 (06): : 567 - 570
  • [26] CYP2D6 gene polymorphism and apatinib affect the metabolic profile of fluvoxamine
    Ye, Zhize
    Chen, Bingbing
    Gao, Nanyong
    Kong, Qihui
    Hu, Xiaoqin
    Lu, Zhongqiu
    Qian, Jianchang
    Hu, Guoxin
    Cai, Jianping
    Wu, Bin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [27] CYP2D6*36 gene arrangements within the CYP2D6 locus:: Association of CYP2D6*36 with poor metabolizer status
    Gaedigk, A
    Bradford, LD
    Alander, SW
    Leeder, JS
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) : 563 - 569
  • [28] Polymorphism of the CYP2D6 gene in women with breast cancer treated with tamoxifen
    de Vasconcelos-Valenca, R. J.
    Melo, M. A.
    Lima, E. M.
    de Sousa, G. V.
    Nazario, A. C.
    da Silva, B. B.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (05) : 700 - 702
  • [29] CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene
    Skierka, Jennifer M.
    Walker, Denise L.
    Peterson, Sandra E.
    O'Kane, Dennis J.
    Black, John Logan, III
    PHARMACOGENOMICS, 2012, 13 (08) : 951 - 954
  • [30] Genetic polymorphism of CYP2D6 in the Japanese population
    Chida, M
    Yokoi, T
    Kosaka, Y
    Chiba, K
    Nakamura, H
    Ishizaki, T
    Yokota, J
    Kinoshita, M
    Sato, K
    Inaba, M
    Aoki, Y
    Gonzalez, FJ
    Kamataki, T
    PHARMACOGENETICS, 1999, 9 (05): : 601 - 605
12345